Navrogen

Developer of cancer immunotherapies and adjuvants for antibodies

placeMerion Station, Pennsylvania, United States calendar_todayFounded 2016 groups4 employees language navrogen.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 301 times.

YearFilings
20201
20213
20224
20234
20242
20255
20262

Investor mix

3 investors on record; lead investors include Tellus BioVentures, Ben Franklin Technology Partners.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon